Rituximab plus chemotherapy, CD34+cell selection and high-dose chemotherapy in advanced stage mantle-cell lymphoma.

被引：0
|
作者：
Martinelli, G [1 ]
Alietti, A [1 ]
Cinieri, S [1 ]
Rabascio, C [1 ]
Corsini, C [1 ]
Agazzi, A [1 ]
De Luzio, K [1 ]
Cocorcchio, E [1 ]
Ferrucci, PF [1 ]
Laszlo, D [1 ]
Bertolini, F [1 ]
机构：
[1] European Inst Oncol, Div Hematoncol, Milan, Italy
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2550
引用
收藏
页码：648A / 648A
页数：1
相关论文
共 50 条
  • [1] Rituximab plus chemotherapy, CD34+cell aelection and high-dose chemotherapy in advanced stage mantle-cell lymphoma
    Martinelli, G
    Alietti, A
    Cinieri, S
    Rabascio, C
    Corsini, C
    Agazzi, A
    De Luzio, K
    Cocorocchio, E
    Ferrucci, PF
    Laszlo, D
    Bertolini, F
    BONE MARROW TRANSPLANTATION, 2003, 31 : S70 - S70
  • [2] High-dose chemotherapy in mantle-cell lymphoma
    Krüger, N
    Hoffknecht, M
    Schmitz, N
    Krüger, W
    Zander, AR
    BONE MARROW TRANSPLANTATION, 1998, 22 : S27 - S27
  • [3] Rituximab/chemotherapy induction treatment followed by high-dose therapy and autologous transplantation in patients with mantle cell lymphoma.
    Thieblemont, C
    Antal, D
    Lacotte-Thierry, L
    Delwail, V
    Bouafia, F
    Tartas, S
    Michallet, AS
    Espinouse, D
    Giraud, C
    Salles, G
    Guilhot, F
    Coiffier, B
    BLOOD, 2004, 104 (11) : 390A - 390A
  • [4] Intensive chemotherapy and autologous stem-cell transplantation plus rituximab is superior to conventional chemotherapy for newly diagnosed advanced stage mantle-cell lymphoma: a matched pair analysis
    Mangel, J
    Leitch, HA
    Connors, JM
    Buckstein, R
    Imrie, K
    Spaner, D
    Crump, M
    Pennell, N
    Boudreau, A
    Berinstein, NL
    ANNALS OF ONCOLOGY, 2004, 15 (02) : 283 - 290
  • [5] Lenalidomide plus Rituximab for Mantle-Cell Lymphoma
    Tsuda, Kenji
    Tanimoto, Tetsuya
    Komatsu, Tsunehiko
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (08): : 792 - 793
  • [6] A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and nontoxic treatment for advanced follicular and mantle cell lymphoma.
    Lazzarino, M
    Arcaini, L
    Bernasconi, P
    Alessandrino, EP
    Gargantini, L
    Cairoli, R
    Orlandi, E
    Astori, C
    Brusamolino, E
    Pagnucco, G
    Colombo, AA
    Calatroni, S
    Iacona, I
    Regazzi, MB
    Morra, E
    BLOOD, 2001, 98 (11) : 394B - 394B
  • [7] Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma
    Thieblemont, C
    Antal, D
    Lacotte-Thierry, L
    Delwail, V
    Espinouse, D
    Michallet, AS
    Traulle, C
    Bouafia-Sauvy, F
    Giraud, C
    Salles, G
    Guilhot, F
    Coiffier, B
    CANCER, 2005, 104 (07) : 1434 - 1441
  • [8] Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy
    Kröger, N
    Hoffknecht, M
    Dreger, P
    Krüger, W
    Zeller, W
    Krüll, A
    Stockschläder, M
    Bittner, S
    Weh, HJ
    Zander, AR
    BONE MARROW TRANSPLANTATION, 1998, 21 (01) : 55 - 57
  • [9] Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy
    N Kröger
    M Hoffknecht
    P Dreger
    W Krüger
    W Zeller
    A Krüll
    M Stockschläder
    S Bittner
    HJ Weh
    AR Zander
    Bone Marrow Transplantation, 1998, 21 : 55 - 57
  • [10] Comparative Effectiveness of Chemotherapy, Rituximab, and Bendamustine in Medicare Beneficiaries With Mantle-Cell Lymphoma
    Fu, Shuangshuang
    Wang, Michael
    Zhao, Hui
    Li, Ruosha
    Lairson, David R.
    Giordano, Sharon H.
    Zhao, Bo
    Du, Xianglin L.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (11): : E616 - E623
12345